Patents
Sitemap › C07 - Organic chemistry › C07J - Steroids › C07J 9 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Patents for C07J 9 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane (4,897)
12/1995
12/06/1995EP0685488A1 Process for producing high-purity cholesterol
12/05/1995US5473087 Preparation process for 20-keto 21(S) hydroxy steroids compounds and intermediates
11/1995
11/30/1995WO1995032215A1 Oxidation of steroids having allylic groups
11/30/1995CA2190500A1 Oxidation of steroids having allylic groups
11/28/1995US5470976 Process for the stereoselective reduction of steroid enelactams
11/22/1995EP0683172A1 11,21-Bisphenyl-19-norpregnane derivatives
11/22/1995CN1030319C 20- and 21-amino steroid
11/21/1995US5468860 Amidation of ester in the presence of magnesium halide7
11/21/1995US5468511 Method for removal of cholesterol and fat from liquid egg yolk with recovery of free cholesterol as a by-product
11/14/1995US5466815 Antilipemic agents
11/02/1995WO1995029186A1 Compositions and methods for cell transformation
11/02/1995CA2188320A1 Compositions and methods for cell transformation
10/1995
10/31/1995US5462933 Modified bile acid conjugates, and their use as pharmaceuticals
10/26/1995WO1995028413A1 17β-SUBSTITUTED 3-CARBOXY STEROIDS THAT INHIBIT 5-α-REDUCTASE
10/18/1995EP0569393B1 Derivatives of dicarboxylic acids having six to twelve carbon atoms and use of these derivatives and dicarboxylic acids alone in the preparation of pharmaceutical compositions for enteral and parenteral nutrition
10/17/1995US5459136 Skin disorders
10/11/1995EP0675721A1 Pharmaceutical compositions comprising contignasterol compounds
10/11/1995EP0675714A1 COMBINATION OF A CHOLESTEROL BIOSYNTHESIS INHIBITOR AND A $g(b)-LACTAM CHOLESTEROL ABSORPTION INHIBITOR
10/10/1995US5457217 Treating bone disorders, osteoporosis
10/03/1995US5455335 Glycosylated steroids
09/1995
09/27/1995EP0673251A1 17 substituted acyl-3-carboxy 3,5-diene steroidals as 5-alpha-reductase inhibitors
09/19/1995US5451575 Method of treating liver dysfunction with 24-R scymnol
09/14/1995WO1995024415A1 Steroid derivatives, pharmaceutical compositions containing them, and their pharmaceutical uses
09/13/1995EP0671411A1 Process for producing provitamin d compound
09/13/1995EP0265519B1 Electrochemiluminescent assays
09/10/1995CA2122639A1 Bile acids for biological and chemical applications and processes for the production thereof
09/06/1995EP0669932A1 17-alpha and 17-beta substituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-alpha-reductase
09/06/1995EP0669931A1 17-alpha-acyl steroids which inhibit 5-alpha-reductase
09/05/1995US5447959 Vitamin A derivatives
08/1995
08/30/1995EP0631500A4 1-g(a)-HYDROXY-24--i(EPI)-VITAMIN D 4?.
08/30/1995CN1107478A Steroalkenol polyfluohydrocarbyl sulfonate compound and its deriv., use and preparing process
08/29/1995US5446177 No increase in intraocular pressure during chronic use
08/29/1995US5446036 13-alkyl-11beta-phenylgonanes
08/22/1995US5443758 A ketone cis- or trans-gonanes; nonlinear optical response
08/17/1995WO1995019186A3 Contrast media for x-ray and magnetic resonance imaging
08/09/1995EP0665752A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof
08/08/1995US5439913 Contraception method using competitive progesterone antagonists and novel compounds useful therein
08/08/1995US5439899 Cosalane and related compounds having activity against aids and aids-related infections
08/02/1995EP0664826A1 Liquid crystalline organosiloxanes containing doristerol.
08/02/1995CN1029398C Method for preparing intermediates for the synthesis of steroid side chains in optically active form
07/1995
07/26/1995EP0664129A2 Epicholesterol for treating dyslipidemia
07/20/1995WO1995019567A1 Synthetic receptors, libraries and uses thereof
07/20/1995WO1995019186A2 Contrast media for x-ray and magnetic resonance imaging
07/20/1995CA2180844A1 Synthetic receptors, libraries and uses thereof
07/19/1995EP0663013A1 Method for delivering nucleic acids into cells
07/05/1995EP0498870B1 Method for extracting minor fatty compounds from bioligical matter
07/04/1995US5430116 Polymers and oligomers of bile acid derivatives, process for their preparation and their use as pharmaceuticals
07/04/1995US5429934 Process for the production of 20-methyl-5,7-pregnadiene-3β,21-diol derivatives using mycobacterium
06/1995
06/28/1995EP0498869B1 Method for extracting minor fatty compounds from biological matter
06/28/1995EP0377743B1 Steroid compounds
06/27/1995US5428182 Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals
06/22/1995WO1995016700A1 Process for producing high-purity cholesterol
06/22/1995WO1995016699A1 Steroid derivative
06/22/1995WO1995016698A1 Conversion of bisnoralcohol to bisnoraldehyde
06/22/1995CA2178900A1 Steroid derivative
06/21/1995EP0658564A1 Electroluminescent compounds and intermediates in their synthesis
06/21/1995EP0658533A1 Process for the oxidation of primary and secondary alcohols to aldehydes and ketones and for the oxidation of 1,2-diols to alpha-ketols and alpha-diketones
06/21/1995CN1028998C Sialic acid sugar radical cholesterol process for preparing them and drug containing them for treating neuronosis
06/20/1995US5426198 Contacting steroid in solution with chromium ion, hydrogen radical source, reducing agent
06/20/1995US5426102 Antigestagenic, antiandrogenic, antiglucocorticoid, antimineralcorticoid properties
06/15/1995WO1995015943A1 21-norvitamin d compounds
06/14/1995EP0656894A1 Isolation of tocopherol and sterol
06/13/1995US5424457 Reacting mixture of sterols, tocopherols, free fatty acids and glycerides with alcohol in presence of catalysts
06/13/1995US5424304 17-aryl-substituted steroidal compounds active on the cardiovascular system
06/08/1995WO1995015165A1 Administration of a 27-hydroxycholesterol or related compound or sterol-27-hydroxylase stimulant to prevent restenosis following vascular endothelial injuri
06/08/1995CA2177822A1 Administration of a 27-hydroxycholesterol or related compound or sterol-27-hydroxylase stimulant to prevent restenosis following vascular endothelial injuri
06/06/1995US5422279 Lipid fractionation
06/01/1995WO1995014662A1 26,28-methylene-1alpha,25-dihydroxyvitamin d2 compounds
05/1995
05/31/1995EP0655458A2 New method of preparation of finasteride
05/30/1995US5420121 Use of 4-cholesten-3-one as an anti-obesity agent
05/26/1995WO1995014032A1 Process for producing 25-hydroxylated cholesterol
05/24/1995DE4343054C1 Prim. or sec. alcohol or 1,2-di:ol oxidn. to aldehyde, ketone, alpha-ketol or alpha-di:ketone
05/17/1995EP0652773A1 The use of nor- and homo- bile acids derivatives as absorption enhancers for medicaments
05/17/1995EP0633892A4 N-T-BUTYL-ANDROST-3,5-DIENE-17-g(b)-CARBOXAMIDE-3-CARBOXYLIC ACID POLYMORPH A.
05/10/1995EP0651643A1 17-ALKYLKETONE STEROIDS USEFUL AS 5-$g(a)-REDUCTASE INHIBITORS
05/10/1995EP0548261B1 Spontaneously dispersible concentrate containing a sterol ester and sterol phosphatide respectively
05/03/1995EP0650496A1 Anti-inflammatory compounds for ophthalmic use
05/02/1995US5412127 Process for extracting minor fatty compounds from a substance of biological origin
04/1995
04/26/1995CN1101916A Compounds
04/26/1995CN1101914A Compounds
04/18/1995US5407926 Ophthalmic composition
04/12/1995EP0647849A2 Detecting the presence of analytes in a sample
04/06/1995WO1995008995A1 Antiobestic agent
04/06/1995DE4334154A1 2-Halo-1,25-dihydroxycholecalciferols, pharmaceutical compositions, use as medicaments and process for the preparation of the cholecalciferols
04/05/1995EP0646126A1 Novel steroids with pregnane skeleton, pharmaceutical compositions containing them and process for preparing same
04/04/1995US5403580 Mixing cholestane gelling agent with organosilicon compound, dissolving, heating to desolventize, gelation
03/1995
03/29/1995EP0644891A1 Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use
03/29/1995CN1100729A Trifluoromethyl steroids and the prepn. method
03/23/1995WO1995007920A1 Nucleotide analogs
03/23/1995WO1995007919A1 Method for dosing therapeutic compounds
03/23/1995CA2171868A1 Method for dosing therapeutic compounds
03/22/1995EP0643723A1 Halogenation using halo-vilsmeier reagent
03/22/1995CN1027976C Method for synthesizing raphanin internal ester analogue
03/21/1995US5399685 Process for the preparation of 20-keto-21 alpha-01-steroids
03/15/1995CN1100102A Method for preparing ursodeoxycholic acid using fowl gall as raw material
03/14/1995US5397775 26,27-dimethylene-1α,25-dihydroxyvitamin D2 and 26,27-dimethylene-24-epi-1α,25-dihydroxyvitamin D2 and methods for preparing same
03/09/1995DE3590020C2 1-Hydroxy-vitamin-D compounds which are unsaturated in the side chain
03/08/1995EP0440752B1 Method for the preparation of 3-desoxy-4-ene steroids
03/07/1995US5395953 Method of preparing hydrindane compounds and hydrindane-related compounds
03/07/1995CA1334668C 13-alkyl-11beta-phenylgonanes
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 49